Metabolically speaking, not everyone responds the same to the same foods. Dr. Sean Gibbons was interviewed for this story highling Gibbons Lab research examining if they could use a model they created to design personalized interventions to optimize the production of short chain fatty acids.
Drug Discovery News
Posted on August 7, 2024
Dr. Sean Gibbons was interviewed for this story focusing on his research that found a link between bowel movement frequency and overall health.
NBC News
Posted on July 16, 2024
Science reporter Torah Kachur interviewed Dr. Sean Gibbons for this radio report showing that the frequency of your bowel movements can tell you a lot about your health.
CBC News
Posted on July 16, 2024
Dr. Lee Hood was interviewed by Dr. Mark Hyman and talked about the tools and techniques to reverse brain aging.
Doctor’s Farmacy Podcast
Posted on July 3, 2024
Drs. Sean Gibbons, Nick Quinn-Bohmann, and Christian Diener are quoted in this story detailing their novel way of simulating a personalized, microbiome-mediated response to diet.
Technology Networks
Posted on June 25, 2024
Dr. Lee Hood spoke with Drs. Grant Cooper and Zinovy Meyler for an interview that spanned the transformative role of AI in healthcare, and much more.
The Performance Initiative Podcast
Posted on June 4, 2024
Drs. Lee Hood and Nathan Price were podcast guests, where they discussed scientific wellness, genome sequencing, genetic vs. lifestyle risks, direct-to-consumer testing, and more.
Melanie Avalon Biohacking Podcast
Posted on May 30, 2024
Dr. Ilya Shmulevich, who passed away in April 2024, was interviewed for this story and talked about his lab’s digital twin project.
Nature
Posted on May 29, 2024
Dr. Sean Gibbons Gibbons is featured in a video for the Environmental Health and Microbiome Research Center (EHMBRACE).
YouTube
Posted on March 9, 2024
ISB-led research highlights the transformative power of informal STEM learning in addressing societal challenges and the ease with which many organizations could provide these important opportunities.
Phys.org
Posted on March 8, 2024
An ISB study found that pregnant patients with lupus or antiphospholipid syndrome have a higher risk for preterm birth, although autoimmune diseases in general are “only weakly associated” with adverse pregnancy outcomes.
Healio
Posted on March 6, 2024
ISB researchers offer promising avenues for exploring multi-disease therapeutic strategies.
Medical Xpress
Posted on March 4, 2024
The association between immune-mediated inflammatory diseases (IMIDs) and adverse pregnancy outcomes varies with the nature of IMID and the presence of comorbidities.
HealthDay
Posted on February 12, 2024
ISB Associate Professor Dr. Jennifer Hadlock discussed her recent paper showing that comorbidities play a major role in poor birth outcomes, such as preterm birth and low birth weight, in patients with specific autoimmune diseases.
Medscape
Posted on February 7, 2024
An ISB-led research project examining autoimmune disease and pregnancy was cited as an example of encouraging critical thinking.
Medriva
Posted on February 6, 2024
ISB President Dr. Jim Heath talked with Science in Seattle in a wide-ranging interview that touched on his paper in Cell Reports showing how T-cell receptors form, his transition from chemistry to biology, challenges facing life scientists, and more.
Science in Seattle
Posted on November 24, 2023
As AI and new imaging tools give researchers vast amounts of data on tumors, they are winning some battles against cancer. ISB President Dr. Jim Heath was interviewed for this extensively reported feature story for Newsweek Magazine.
Newsweek
Posted on November 22, 2023
ISB Associate Professor Dr. Sean Gibbons spoke with Mark O. Martin from the University of Puget Sound. Gibbons talked about how the study of host-associated microbial communities gives us insights into evolution, ecology and human health.
Matters Microbial podcast
Posted on November 10, 2023
ISB and NED Biosystems will collaborate on an intriguing clinical trial that aims to use a cocktail of several marketed medications at low doses to reverse cancer’s onset or regrowth. ISB Co-founder Lee Hood and NED Biosystems founder and CEO Rebecca Lambert announced the deal.
Inside Precision Medicine
Posted on November 8, 2023
Sean Gibbons was quoted in this Bloomberg Businessweek story examining Viome and the often questionable microbiome-wellness startup space.
Bloomberg Businessweek
Posted on October 30, 2023
